UCrest Bhd (0005) fair value: what the stock is really worth
We calculate from audited financials what UCrest Bhd is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch UCrest Bhd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range 0.0550 MYR – 0.4350 MYR · fair‑value band 0.0660 MYR – 0.1140 MYR · the 0.0600 MYR price screens below the 0.0900 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 13, 2026.
UCrest Berhad, an investment holding company, engages in the design, development, and marketing of information technology related products and services in Malaysia and Singapore.
Show more
UCrest Berhad, an investment holding company, engages in the design, development, and marketing of information technology related products and services in Malaysia and Singapore. The company offers iMedic cloud hospital that is used by doctors and patients for the diagnosis, management, and treatment of chronic diseases, such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases in the United States, China, Singapore, Malaysia, Taiwan, Indonesia, Vietnam, and the Middle East. It also provides mobile healthcare services. The company was formerly known as Palette Multimedia Berhad and changed its name to UCrest Berhad in November 2017. UCrest Berhad was incorporated in 1997 and is based in Petaling Jaya, Malaysia.
Stock analysis
UCrest Bhd (0005) currently trades at 0.0600 MYR, while our model-based Fair Value estimate is 0.0900 MYR, implying the stock looks roughly 33.3% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 0.1700 MYR per share, and 18 of the 24 models we run sit above the 0.0600 MYR price.
Bear case: the Asset-Based group reads lowest at 0.0400 MYR, and 6 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.0660 MYR (bear) to 0.1140 MYR (bull), the price of 0.0600 MYR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
UCrest Bhd reported revenue of 18.1M MYR in FY2024 versus 25.5M MYR in FY2020, a compound −8.2%/yr. Reported net income was 4.7M MYR in FY2024, compounding −20.0%/yr from FY2020.
Key figures
Market cap 48.3M MYR (≈ $11.9M) · P/S ratio 3.45 · Net margin 26.1% · Return on equity 4.9% · Return on assets (EBIT) −12.9% · Operating margin −22.0% · Revenue (TTM) 14.0M MYR · Revenue growth (YoY) −44.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at 50%, 0005 screens cheaper than that median.
Fair Value models
Bear 0.0660 MYRFair Value 0.0900 MYRBull 0.1140 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.64/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+13.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.1%
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.6%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
What shareholders gained per year (last 5 years), in MYR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−7.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.2%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−17% vs 0%, slowing
Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−187% → 26%
2024 sits 120% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+1.6%
Yearly growth needed for the next five years to justify today's price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 129 stocks
Beats the industry median on 8/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score52 · Below median
Fair Value upside+29% · Top 25%
Profitability
Return on equity (TTM)5% · Above median
Return on assets1% · Above median
Net margin (TTM)15% · Top 25%
Operating margin (TTM)−22% · Bottom 25%
Growth and dividend
Revenue growth−45% · Bottom 25%
Valuation Multiplesvs Health Information Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "UCrest Bhd Fair Value". https://www.fairvalue-calculator.com/stock/0005
Frequently asked questions
Is UCrest Bhd (0005) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 0.0900 MYR versus a price of 0.0600 MYR, about +50% upside (undervalued).
What is the fair value of 0005?
Our model-based fair value for UCrest Bhd is 0.0900 MYR (as of Sep 13, 2026), built from audited fundamentals. The current price: 0.0600 MYR.
What is the quality score of 0005?
UCrest Bhd has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for UCrest Bhd (0005)?
Our model-based price target is the fair value of 0.0900 MYR (as of Sep 13, 2026) from 24 valuation models. Cautious scenario 0.0660 MYR, optimistic scenario 0.1140 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the UCrest Bhd stock forecast for 2026?
Our models put fair value at 0.0900 MYR, about +50% upside versus a price of 0.0600 MYR (undervalued). Cautious scenario 0.0660 MYR, optimistic scenario 0.1140 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of UCrest Bhd (0005)?
UCrest Bhd reported trailing-twelve-month revenue of about 14.0M MYR (latest available figure, as of Sep 13, 2026).
What growth is priced into UCrest Bhd (0005)?
For today's price to be fair in a discounted-cash-flow model, UCrest Bhd would have to grow free cash flow by +1.6 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.1 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of 0005 use?
Our models discount UCrest Bhd at 9.7 %: a base by market capitalisation (nano), damped by beta 0.11, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For UCrest Bhd that is +1.6 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has UCrest Bhd (0005) delivered so far?
Over the past 5 years revenue at UCrest Bhd grew +8.1 % a year. The price currently implies +1.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of UCrest Bhd (0005) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into UCrest Bhd (+1.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of UCrest Bhd (0005)?
The free-cash-flow yield on the price is 4.67 %: that much free cash flow UCrest Bhd produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of UCrest Bhd (0005)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For UCrest Bhd it is 0.0900 MYR per share (as of Sep 13, 2026), against a price of 0.0600 MYR. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is UCrest Bhd stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 0005 trades below its calculated fair value: price 0.0600 MYR, fair value 0.0900 MYR, a gap of about +50% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0005?
No. The price is what the market pays today (0.0600 MYR); the fair value is what the company's own numbers justify (0.0900 MYR). For UCrest Bhd the two are 0.0300 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is UCrest Bhd worth?
The market values UCrest Bhd at about 48.3M MYR (market capitalisation, as of Sep 13, 2026). Per share that is 0.0600 MYR; our models calculate a fair value of 0.0900 MYR per share.
What do the bullish and bearish scenarios say about 0005?
Our models span a range for UCrest Bhd: cautious scenario 0.0660 MYR, base 0.0900 MYR, optimistic 0.1140 MYR per share (as of Sep 13, 2026, price 0.0600 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of UCrest Bhd (0005)?
Balance-sheet figures for UCrest Bhd (as of Sep 13, 2026): return on equity 4.9%. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is 0005 from its 52-week high?
UCrest Bhd trades at 0.0600 MYR, about 40% below its 52-week high of 0.1000 MYR and 9% above the low of 0.0550 MYR (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0900 MYR is for.
Which stocks are comparable to UCrest Bhd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is UCrest Bhd stock attractive at the current price?
The data as of Sep 13, 2026: price 0.0600 MYR, calculated fair value 0.0900 MYR (+50%), Quality Score 52/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0005 calculated?
We run UCrest Bhd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.0900 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 16.1 % above its aggregate fair value. UCrest Bhd currently trades 50 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of UCrest Bhd (0005)?
The closing price on Sep 18, 2026 was 0.0600 MYR. Our model-based fair value is 0.0900 MYR, about +50% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with UCrest Bhd right now?
The price is below even our cautious bear case (0.0660 MYR). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (52/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of UCrest Bhd
How large is the market capitalisation of UCrest Bhd (0005)?
The market capitalisation of UCrest Bhd is 48.3M MYR (≈ $11.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of UCrest Bhd (0005)?
The price-to-sales ratio of UCrest Bhd is 3.45 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of UCrest Bhd (0005)?
The net margin of UCrest Bhd is 26.1% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of UCrest Bhd (0005)?
The return on equity (ROE) of UCrest Bhd is 4.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of UCrest Bhd (0005)?
On an EBIT basis the return on assets of UCrest Bhd is −12.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of UCrest Bhd (0005)?
The operating margin of UCrest Bhd is −22.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at UCrest Bhd (0005)?
Revenue at UCrest Bhd is growing −44.8% versus a year earlier (3y avg +13.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at UCrest Bhd (0005)?
Earnings per share at UCrest Bhd are growing −59.0% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch UCrest Bhd in the live analysis
One click puts UCrest Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
